Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
McKinsey
QuintilesIMS
Farmers Insurance
Daiichi Sankyo
UBS
Federal Trade Commission
Cipla
Mallinckrodt

Generated: October 23, 2017

DrugPatentWatch Database Preview

Naproxen sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naproxen sodium and what is the scope of naproxen sodium freedom to operate?

Naproxen sodium
is the generic ingredient in eight branded drugs marketed by Bayer, Hamilton Pharms, Glenmark Pharms Ltd, Actavis Labs Fl Inc, Purepac Pharm, Bionpharma Inc, Aurobindo Pharma Ltd, Ivax Sub Teva Pharms, Amneal Pharms Ny, Contract Pharmacal, Pliva, Teva, Able, Marksans Pharma, Sandoz, Alvogen Malta, Granules India, Watson Labs, Roxane, Perrigo, Atnahs Pharma Us, Mylan, Dr Reddys Labs Inc, Lnk Intl Inc, Hikma, Sun Pharm Inds Ltd, Dr Reddys Labs Ltd, Teva Pharms, and Pernix Ireland Ltd, and is included in thirty-nine NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-two drug master file entries for naproxen sodium. One hundred and sixty-two suppliers are listed for this compound.

Summary for Generic Name: naproxen sodium

US Patents:5
Tradenames:8
Applicants:29
NDAs:39
Drug Master File Entries: see list42
Suppliers / Packagers: see list162
Bulk Api Vendors: see list52
Clinical Trials: see list2,576
Patent Applications: see list7,183
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:naproxen sodium at DailyMed

Pharmacology for Ingredient: naproxen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074162-001Dec 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074142-002Dec 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL090545-001Mar 16, 2011OTCNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
NAPROXEN SODIUM
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL075416-001Aug 27, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Hamilton Pharms
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074106-002Aug 31, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Pernix Ireland Ltd
TREXIMET
naproxen sodium; sumatriptan succinate
TABLET;ORAL021926-001Apr 15, 2008RXYesYes► Subscribe► SubscribeY► Subscribe
Pernix Ireland Ltd
TREXIMET
naproxen sodium; sumatriptan succinate
TABLET;ORAL021926-001Apr 15, 2008RXYesYes► Subscribe► SubscribeY► Subscribe
Sandoz
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074162-002Dec 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Pernix Ireland Ltd
TREXIMET
naproxen sodium; sumatriptan succinate
TABLET;ORAL021926-001Apr 15, 2008RXYesYes► Subscribe► SubscribeY► Subscribe
Watson Labs
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL074195-001Dec 21, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: naproxen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
NAPRELAN
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL020353-001Jan 5, 1996► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX
naproxen sodium
TABLET;ORAL018164-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
NAPRELAN
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL020353-003Jan 5, 1996► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX
naproxen sodium
TABLET;ORAL018164-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987► Subscribe► Subscribe
Alvogen Malta
NAPRELAN
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL020353-002Jan 5, 1996► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX
naproxen sodium
TABLET;ORAL018164-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Atnahs Pharma Us
ANAPROX DS
naproxen sodium
TABLET;ORAL018164-003Sep 30, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
Dow
Daiichi Sankyo
Queensland Health
US Department of Justice
Colorcon
Accenture
US Army
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot